Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deutetrabenazine for Tardive Dyskinesia in Adults With IDD
NCT06997198Phase 4Recruiting
- Sponsor
- University Hospitals Cleveland Medical Center
- Start
- Jun 2026
- Primary completion
- Oct 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of deutetrabenazine in tardive dyskinesia (TD), sponsored by University Hospitals Cleveland Medical Center. Started Jun 2026; status: recruiting.
02
Drugs
deutetrabenazine
03
Conditions
tardive dyskinesia (TD)
Beyond the preview
Go deeper on NCT06997198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06997198.